A Double-blind Randomised, Placebo-controlled Clinical Trial to Test Ambroxol Treatment in ALS

NCT05959850 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Ambroxol
DRUG: Placebo

Sponsor

The Florey Institute of Neuroscience and Mental Health

Collaborators

[object Object]
[object Object]